CDSCO License for Magnetoencepha lography system
Medical Device Information
Intended Use
Intended to non-invasively detect, measure, and display bio- magnetic signals produced by electrically-active cortical brain tissue, and that provide diagnostic information about the location of the active tissue responsible for cognitive brain functions relative to the surrounding brain anatomy

Comprehensive Guide to CDSCO Licensing for Magnetoencephalography Systems (Class B)
Magnetoencephalography (MEG) systems are advanced neurological diagnostic devices designed to non-invasively detect, measure, and display bio-magnetic signals generated by electrically active cortical brain tissue. These systems provide critical diagnostic insights by mapping the location of active brain regions responsible for cognitive functions, aiding clinicians in precise neurological assessments and interventions.
Given the sophisticated nature and clinical significance of MEG systems, regulatory compliance with the Central Drugs Standard Control Organization (CDSCO) is paramount for manufacturers and importers targeting the Indian market. As seasoned regulatory consultants with over 25 years of experience helping 500+ companies navigate the CDSCO licensing landscape, we understand the nuances and provide actionable insights tailored specifically for Class B neurological devices like the Magnetoencephalography system.
CDSCO Regulatory Framework for Magnetoencephalography Systems
The CDSCO regulates medical devices under the Medical Device Rules (MDR) 2017, amended periodically to align with global best practices. Magnetoencephalography systems fall under the neurological device category and are classified as Class B (Low-Moderate Risk) based on their intended use and potential impact on patient safety.
This classification mandates obtaining a manufacturing license from the State Licensing Authority through the MD5 licensing process (Application Form MD3). The regulatory framework ensures thorough evaluation of technical documentation, quality management systems, and product safety before market authorization.
For detailed classification criteria, refer to the Medical Device Classification guide.
Risk Classification and License Requirements for Class B Devices
Class B devices are considered low to moderate risk, requiring a robust yet streamlined regulatory pathway. The MD5 license process applies to manufacturing within India, granting the license at the state level. The key steps include obtaining a Test License (Form MD13), product testing at government-approved laboratories, document submission, and audit by notified bodies.
Manufacturers must demonstrate compliance with essential principles and maintain a comprehensive Quality Management System (QMS) aligned with ISO 13485 standards.
Manufacturing License Process (MD5 License) for Magnetoencephalography Systems
The MD5 license application process involves the following practical steps:
Test License Application (Form MD13): Initiate the process by applying for a test license, which typically takes 1.5 to 2 months for approval. This license permits product testing.
Product Testing: Conduct mandatory tests at CDSCO-recognized laboratories. Access the list of approved Testing Laboratories for your device category.
Documentation Preparation: Compile technical files, including Device Master File (DMF), Plant Master File (PMF), risk management, and QMS documents.
License Application (Form MD3): Submit the manufacturing license application via the CDSCO MD Online Portal.
Audit by Notified Bodies: Undergo an audit by a notified body listed on the Notified Bodies List to verify compliance.
Query Resolution: Address any observations or queries raised by the CDSCO or notified body.
License Grant (Form MD5): Upon successful review and audit, the manufacturing license is granted.
The entire process generally spans 3 to 4 months, allowing for thorough evaluation while enabling timely market entry.
For a detailed walkthrough, our MD5 License Guide provides step-by-step instructions.
Manufacturing License Documents Required
Accurate and complete documentation is critical to avoid delays. For the Magnetoencephalography system (Class B), the following documents must be submitted:
- Company Constitution: Incorporation certificate, partnership deed, or equivalent.
- Proof of Ownership/Lease of Manufacturing Premises: Valid property documents.
- Technical Staff Qualification and Experience: CVs and qualifications of key personnel.
- Fire Safety and Pollution Control NOCs: Approvals from local authorities.
- Device Master File (DMF): Detailed product specifications, design, and manufacturing processes. Our comprehensive Device Master File guide assists in preparation.
- Plant Master File (PMF): Description of manufacturing facilities and quality systems. Refer to our Plant Master File Guide.
- Essential Principles Compliance Checklist: Demonstrating adherence to regulatory safety and performance requirements.
- Risk Management File: Documented risk analysis and mitigation strategies. Implement best practices from our Risk Management guide.
- Product Test Reports: From CDSCO-approved laboratories.
- Labels and Instructions for Use (IFU): Compliant with regulatory standards.
- Quality Management System (QMS) Documents: Procedures, manuals, and records aligned with ISO 13485.
Maintaining organized, precise documentation expedites the review process and demonstrates your commitment to quality.
Import License Process (MD15 License) for Magnetoencephalography Systems
For importers, the MD15 license is mandatory and is granted by the Central Licensing Authority. The process, taking approximately 5 to 6 months, does not require a test license but entails rigorous document verification:
Document Preparation: Including manufacturing license from the country of origin, Free Sale Certificate, ISO 13485:2016 certification, CE Certificate if applicable, DMF, PMF, and Wholesale License.
Application Submission: File MD15 license application via the CDSCO MD Online Portal.
Department Review and Query Resolution: Address any clarifications sought by CDSCO.
License Issuance: Upon satisfactory review, the import license (Form MD15) is granted.
We provide detailed guidance on import licensing in our Import License Guide.
Timeline and Processing Duration
Process Stage | Duration |
---|---|
Test License (MD13) | 1.5 - 2 months |
Product Testing | 1 - 1.5 months |
Documentation Preparation | Concurrent |
License Application (MD3) | Immediate once docs ready |
Notified Body Audit | 1 month |
Query Resolution | 2 - 4 weeks |
License Grant (MD5) | Upon clearance |
Total Estimated Time: Approximately 3 to 4 months from start to finish for manufacturing license.
For imports, expect 5 to 6 months due to centralized review.
Government Fees and Costs
For Class B devices such as the Magnetoencephalography system, the CDSCO fee structure for the MD5 manufacturing license is as follows:
- Application Fee: INR 5,000 per application
- Product Fee: INR 500 per product
Additional costs include:
- Testing fees at government-approved labs (variable based on tests required)
- Audit fees payable to the notified body
- Documentation preparation and consultancy fees (if applicable)
For import licenses (MD15), the fees are higher, reflecting the central authority’s oversight:
- Site Fee: USD 2,000 per site
- Product Fee: USD 1,000 per product
Budgeting for these fees upfront helps avoid cash flow interruptions.
Common Challenges and Solutions
Challenge: Delays in document preparation and test report acquisition.
Solution: Engage early with testing laboratories and use our detailed document checklists to ensure completeness.
Challenge: Complex audit requirements causing non-conformities.
Solution: Pre-audit mock inspections by experienced consultants can identify gaps.
Challenge: Misclassification leading to incorrect application forms.
Solution: Confirm device classification using CDSCO guidelines or our classification resource.
Challenge: Handling queries and communication with CDSCO.
Solution: Maintain clear, timely correspondence and have regulatory experts assist in technical responses.
Expert Consultation and Support
Navigating the CDSCO licensing process for a complex device like the Magnetoencephalography system demands precision and expertise. Our team, with over 25 years of regulatory experience and a track record of supporting 500+ successful licenses, offers tailored consulting services including:
- Comprehensive gap analysis
- Documentation preparation and review
- Coordination with notified bodies and testing labs
- Regulatory strategy and submission management
Partnering with seasoned consultants minimizes risks and accelerates your product’s time-to-market.
Getting Started with Your CDSCO License Application
To kickstart your CDSCO licensing journey for the Magnetoencephalography system, follow these practical steps:
Verify Device Classification: Confirm your device is Class B using official MDR guidelines.
Gather Core Documents: Begin compiling company constitution, technical staff details, and facility ownership documents.
Plan Product Testing: Identify CDSCO-approved testing labs early by visiting the Testing Laboratories list.
Apply for Test License (MD13): Submit your test license application through the CDSCO MD Online Portal.
Prepare DMF and PMF: Use our detailed guides to develop comprehensive master files.
Implement Risk Management: Establish your risk management process reflecting the device’s neurological functions.
Schedule Notified Body Audit: Coordinate with a notified body from the official Notified Bodies List.
Submit Manufacturing License Application (MD3): Once testing and document preparation complete, apply online.
Respond Promptly to Queries: Maintain open communication lines to expedite approval.
Starting early and following these steps diligently ensures a smooth licensing experience and timely market access for your Magnetoencephalography system.
For personalized assistance or more detailed insights, contact our regulatory experts who have successfully guided numerous neurological device manufacturers through the CDSCO process. Your trusted partner in Indian medical device compliance.